Hedge fund calls for departure of Actelioin directors


p { margin-bottom: 0.08in; } The US hedge fund Elliott Associates (USD17bn in assets) has called for the resignation of the president and CEO of Actelion, a Swiss biotech firm in which it is the largest shareholder, the Financial Times reports. In a letter to directors on Thursday, of which a copy was obtained by the newspaper, the hedge fund is severely critical of the management of the firm.